ELMWOOD PARK, N.J., May 13, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a strategic collaboration with the Westchester Medical Center ...

ELMWOOD PARK, N.J., Aug. 16, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory ...

MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his role ...

This clinical diagnostic laboratory services provider has seen a flat track record when it comes to current year estimate revisions over the past few weeks and the consensus for earnings hasn’t been ...

Bio-Reference Laboratories, Inc. has announced it has executed a Purchase Agreement for the acquisition of GeneDx and released its third quarter, fiscal year 2006 earnings for the three months ending ...

Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares ...

Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ...

Elmwood Park, NJ, May 02, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new ...

ELMWOOD PARK, N.J., March 17, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City Health and Hospital ...

One day after 11 NFL teams experienced false positive COVID-19 tests of players, coaches and staff stemming from a contamination in a New Jersey testing laboratory, BioReference Laboratories issued a ...